SCM
UTHR icon

Scopia Capital Management’s United Therapeutics UTHR Stock Holding History

Scopia Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-269,455
Closed -$48.3M – 18
2021
Q2 		$48.3M Buy
269,455
+60,170
+29% +$11.5M 6.56% 7
2021
Q1 		$35M Buy
209,285
+3,759
+2% +$627K 4.34% 8
2020
Q4 		$31.2M Buy
+205,526
New +$27M 3.95% 9
2017
Q3 		– Sell
-705,003
Closed -$91.5M – 40
2017
Q2 		$91.5M Sell
705,003
-1,668,184
-70% -$208M 1.89% 22
2017
Q1 		$321M Sell
2,373,187
-875,682
-27% -$133M 5.93% 7
2016
Q4 		$466M Sell
3,248,869
-843,832
-21% -$108M 8.83% 3
2016
Q3 		$483M Sell
4,092,701
-208,651
-5% -$25.1M 8.52% 2
2016
Q2 		$456M Buy
4,301,352
+82,071
+2% +$9.15M 9.41% 2
2016
Q1 		$470M Buy
4,219,281
+1,370,698
+48% +$173M 8.77% 2
2015
Q4 		$446M Buy
2,848,583
+2,714
+0.1% +$395K 8.85% 2
2015
Q3 		$373M Buy
2,845,869
+734,960
+35% +$118M 8.01% 3
2015
Q2 		$367M Sell
2,110,909
-304,777
-13% -$54.8M 7.13% 4
2015
Q1 		$417M Sell
2,415,686
-541,804
-18% -$82.6M 9.01% 2
2014
Q4 		$383M Buy
2,957,490
+323,001
+12% +$41.6M 7.13% 4
2014
Q3 		$339M Buy
2,634,489
+2,029,567
+336% +$209M 6.91% 3
2014
Q2 		$53.5M Buy
+604,922
New +$58.2M 1.38% 21

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Scopia Capital Management's UTHR Position: Q3 2021 in Review

Scopia Capital Management sold out of United Therapeutics (UTHR) in Q3 2021, closing a stake of 269,455 shares — an estimated $48.3M sold.

Scopia Capital Management first reported a position in UTHR in Q2 2014 and held it in 16 quarters. The position peaked at $483M in Q3 2016. 425 funds tracked by Wall St. Rank hold UTHR as of Q3 2021.

  • Scopia Capital Management reported no remaining United Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Scopia Capital Management sold 269,455 United Therapeutics shares in Q3 2021, an estimated $48.3M.
  • Scopia Capital Management first reported a position in United Therapeutics in Q2 2014 and held it in 16 quarters.
  • Scopia Capital Management's United Therapeutics position peaked at $483M in Q3 2016.
  • 425 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2021.

Based on Scopia Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.